GLP-1SM
A first-generation GLP-1 receptor agonist. Researched for: glucose regulation, appetite signaling, and insulin sensitivity in preclinical models. 200+ published studies. 3-lab independent COA on every batch. 3-lab independent COA on every batch.
What is GLP-1SM?
GLP-1SM is a single GLP-1 (glucagon-like peptide-1) receptor agonist — the foundational compound class behind the metabolic research revolution. With over 200 published studies, it is one of the most extensively investigated peptides in glucose regulation, appetite signaling, and insulin sensitivity research.
As a GLP-1 receptor agonist, GLP-1SM mimics the incretin hormone GLP-1, binding to and activating GLP-1 receptors. This mechanism has been examined for its role in metabolic pathway modulation, pancreatic beta-cell signaling, and satiety center activation in preclinical research. Human clinical data exist for approved pharmaceutical formulations of this molecule; they do not describe research-grade material and no human conclusion should be drawn from this page.
SMART MD also carries related next-generation compounds: GLP-2TZ (dual GIP/GLP-1 receptor agonist) and GLP-3 RT (triple GIP/GLP-1/glucagon receptor agonist) — representing the forefront of incretin research.
Published research areas
Glucose regulation
Extensively examined for its effects on blood glucose homeostasis through GLP-1 receptor activation. Research examines its role in glycemic control signaling, insulin secretion stimulation, and glucagon suppression in metabolic models.
Appetite signaling
Published research examines GLP-1SM's interaction with hypothalamic satiety centers and its effects on food intake regulation, gastric emptying rate, and reward-pathway modulation in preclinical models.
Metabolic pathway modulation
Studies investigate GLP-1SM's broader metabolic effects including lipid metabolism, cardiovascular and hepatic marker changes, and systemic inflammatory marker modulation in preclinical models.
Insulin sensitivity
Research explores GLP-1SM's effects on peripheral insulin sensitivity, beta-cell preservation, and pancreatic function in models of metabolic dysfunction and insulin resistance.
Available formulations at SMART MD
SMART MD quality standard for GLP-1SM
- HPLC purity analysis — 99%+ verified. Identity and purity confirmed via high-performance liquid chromatography.
- Mass spectrometry — molecular weight confirmation. Verifies correct peptide sequence and structure.
- LAL endotoxin assay — <5 EU/mg. Bacterial endotoxin safety verification.
- 3 independent U.S. laboratories — rotating panel. No single lab relationship can compromise verification integrity.
- Lot-specific COA — publicly verifiable at smartmdpeptides.com/verify before you reach out.
Questions about this compound?
A SMART rep can walk you through the formulations we document, the lot-specific COA for any batch, purity and endotoxin data, and storage and handling requirements for your protocol. Leave your name, email, phone, and what you're researching — a rep follows up within one business day. Research use only: we do not provide dosing, administration, or human-use guidance of any kind, and nothing we send is medical advice.
GLP-1SM FAQ
What is GLP-1SM?+
GLP-1SM is a GLP-1 receptor agonist — a peptide that mimics the incretin hormone GLP-1. It is one of the most extensively studied compounds in metabolic research, with 200+ published studies examining its effects on glucose regulation, appetite signaling, and metabolic pathway modulation.
What GLP-1SM formulations does SMART MD document?+
Research-grade GLP-1SM with 3-lab COA verification is available at SMART MD Peptides in 10mg and 20mg formulations. Every batch is publicly verifiable at smartmdpeptides.com/verify. Purity is reported per lot on that batch's COA. Reach out and a SMART rep will confirm current formulations and documentation.
How does research-grade material differ from an approved pharmaceutical product?+
They are different products under different regulatory regimes, manufactured for different purposes, and they are not substitutes for one another. An approved pharmaceutical product is manufactured under cGMP for a specific approved clinical indication, carries FDA-approved labeling, and is dispensed by prescription. Research-use-only material is supplied for laboratory research by qualified researchers, is not approved or evaluated by the FDA for any use, is not for human or animal consumption, and carries no clinical labeling. Clinical data generated with an approved product describes that product and does not describe research-grade material.
What is the legal status of research GLP-1SM?+
Research-grade GLP-1SM is legal to acquire for research purposes. It is classified as a research-use-only compound. Qualified researchers and research institutions may request documentation for preclinical laboratory research. Lot-specific COA documentation accompanies every release.
What are GLP-2TZ and GLP-3 RT?+
GLP-2TZ is a dual GIP/GLP-1 receptor agonist — it activates two incretin receptors simultaneously. GLP-3 RT is a triple GIP/GLP-1/glucagon receptor agonist — the newest generation targeting three metabolic pathways. Both are available at SMART MD Peptides as related next-generation compounds building on GLP-1 research.